scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Hyon-Seung Yi | Q64515654 |
P2093 | author name string | Jin-Seok Byun | |
P2860 | cites work | Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo | Q46945116 |
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies | Q24598772 | ||
The Role of Innate Immunity in Alcoholic Liver Disease | Q26773226 | ||
Liver natural killer cells: subsets and roles in liver immunity | Q26774237 | ||
Kupffer cells in the liver | Q26822031 | ||
Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophils | Q28218165 | ||
B cell-activating factor controls the production of adipokines and induces insulin resistance | Q28241621 | ||
Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease | Q82581144 | ||
Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression | Q82639981 | ||
The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis | Q83195671 | ||
Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis | Q83679148 | ||
Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation | Q84527447 | ||
Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates | Q84723541 | ||
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet | Q84845677 | ||
NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses | Q84964668 | ||
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease | Q85068847 | ||
3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance | Q85676987 | ||
Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. | Q50590704 | ||
Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. | Q51752154 | ||
Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. | Q53536111 | ||
Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. | Q53536436 | ||
Butyrate protects liver against ischemia reperfusion injury by inhibiting nuclear factor kappa B activation in Kupffer cells. | Q54337513 | ||
Role of immunodeficient animal models in the development of fructose induced NAFLD. | Q54337526 | ||
Intrahepatic gene expression in human alcoholic hepatitis. | Q54595370 | ||
TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. | Q54707207 | ||
Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis | Q61764200 | ||
Influence of ethanol consumption on natural killer cell activity in mice | Q69547488 | ||
Portal tract macrophages are increased in alcoholic liver disease | Q69737535 | ||
Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis | Q70992838 | ||
Inactivation of Kupffer cells prevents early alcohol-induced liver injury | Q72094198 | ||
Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat | Q73023401 | ||
Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1 | Q73424895 | ||
TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease | Q74514030 | ||
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients | Q77318114 | ||
Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics | Q77933506 | ||
Chronic alcohol consumption is associated with changes in the distribution, immunophenotype, and the inflammatory cytokine secretion profile of circulating dendritic cells | Q80040530 | ||
Serum leptin in patients with alcoholic liver disease | Q80086869 | ||
Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis | Q80162138 | ||
A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury | Q80696372 | ||
Alcohol Consumption Decreases IL-2-Induced NF-kappaB Activity in Enriched NK Cells from C57BL/6 Mice | Q44406858 | ||
Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice | Q44665378 | ||
Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-kappaB and STAT3 signaling pathways | Q44830103 | ||
Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption | Q44887156 | ||
Energy restriction restores the impaired immune response in overweight (cafeteria) rats | Q44953669 | ||
Mechanisms of alcohol-induced suppression of B-cell response | Q44992595 | ||
T-cell activation after chronic ethanol ingestion in mice | Q45185219 | ||
Kupffer cell function in chronic ethanol-fed rats. | Q45287580 | ||
Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. | Q45336150 | ||
The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. | Q46367336 | ||
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. | Q46614190 | ||
Adipocytokines: mediators linking adipose tissue, inflammation and immunity | Q29619393 | ||
NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice | Q30277911 | ||
Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke | Q33526964 | ||
Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance | Q33604466 | ||
Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion | Q33604905 | ||
Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota | Q33685907 | ||
C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis | Q33750735 | ||
Alcohol facilitates CD1d loading, subsequent activation of NKT cells, and reduces the incidence of diabetes in NOD mice | Q33869564 | ||
Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. | Q33902002 | ||
Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. | Q33905038 | ||
Pathophysiological roles of interleukin-18 in inflammatory liver diseases | Q33916627 | ||
Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. | Q34031152 | ||
Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. | Q34060210 | ||
Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis | Q34072530 | ||
Alcohol affects the late differentiation of progenitor B cells | Q34410146 | ||
Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice | Q34533851 | ||
Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection | Q34756669 | ||
Endocannabinoids in liver disease | Q34776919 | ||
BAFF knockout improves systemic inflammation via regulating adipose tissue distribution in high-fat diet-induced obesity | Q35040658 | ||
Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death | Q35061420 | ||
Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C. | Q35155996 | ||
Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice | Q35224555 | ||
High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability | Q35594503 | ||
Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study | Q35753739 | ||
TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration | Q35817788 | ||
CD4+ROR γ t++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis | Q35855499 | ||
Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease | Q35879532 | ||
Stabilization of tumor necrosis factor-alpha mRNA in macrophages in response to chronic ethanol exposure | Q35982209 | ||
Chronic alcohol consumption impairs distribution and compromises circulation of B cells in B16BL6 melanoma-bearing mice | Q36132281 | ||
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis | Q36168809 | ||
Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice | Q36243894 | ||
Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity | Q36371566 | ||
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase | Q36377312 | ||
Chronic alcohol increases CD8+ T-cell immunosenescence in simian immunodeficiency virus-infected rhesus macaques | Q36404961 | ||
The relationship between alcohol consumption and cortisol secretion in an aging cohort | Q36494426 | ||
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis | Q36673866 | ||
Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration | Q36674421 | ||
Organ-specific features of natural killer cells | Q36750759 | ||
Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice | Q36901235 | ||
Eosinophils secrete IL-4 to facilitate liver regeneration | Q36932394 | ||
The current immune function of hepatic dendritic cells. | Q36988431 | ||
Liver: An organ with predominant innate immunity | Q37048206 | ||
Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin | Q37053862 | ||
Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice | Q37134825 | ||
Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis | Q37144593 | ||
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases | Q37326768 | ||
Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis | Q37362066 | ||
In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha | Q37403094 | ||
NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease | Q37526716 | ||
Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress | Q37819737 | ||
Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend? | Q38121575 | ||
Immune surveillance by the liver | Q38139201 | ||
Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping | Q38315752 | ||
Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease | Q38320784 | ||
Role of adaptive immunity in alcoholic liver disease | Q38333417 | ||
Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis | Q38336681 | ||
Chronic alcohol consumption inhibits peripheral NK cell development and maturation by decreasing the availability of IL-15. | Q39193836 | ||
Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes | Q40097681 | ||
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver. | Q40258465 | ||
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice | Q40333287 | ||
B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease | Q40707257 | ||
Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay | Q41187748 | ||
Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess | Q41455865 | ||
Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice | Q41548774 | ||
Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease | Q41668234 | ||
Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. | Q42050277 | ||
Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling | Q42174682 | ||
Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes | Q42183683 | ||
Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats | Q43130477 | ||
Chronic alcohol consumption is associated with an increased cytotoxic profile of circulating lymphocytes that may be related with the development of liver injury | Q43143114 | ||
Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. | Q43568327 | ||
Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells | Q43585852 | ||
ICAM-1 is involved in the mechanism of alcohol-induced liver injury: studies with knockout mice | Q43607619 | ||
Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice | Q43657691 | ||
Delivery of IkappaB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats | Q43814817 | ||
Chronic ethanol consumption by mice results in activated splenic T cells. | Q44253575 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human digestive system | Q9649 |
alcoholic liver disease | Q558404 | ||
metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
alcohol and health | Q11290178 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 6862439 | |
P577 | publication date | 2017-08-09 | |
P1433 | published in | BioMed Research International | Q17509958 |
P1476 | title | Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease | |
P478 | volume | 2017 |
Q92278975 | Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver |
Q88499459 | Intrahepatic T-Cell Receptor β Immune Repertoire Is Essential for Liver Regeneration |
Q47205404 | Metabolomics technology and bioinformatics for precision medicine. |
Q91281532 | Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice |
Q57050508 | Primary rat LSECs preserve their characteristic phenotype after cryopreservation |
Q91590335 | Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune ceRNA networks |
Q64897562 | Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease. |
Q64097348 | T-cell senescence contributes to abnormal glucose homeostasis in humans and mice |
Q94093775 | UEG Week 2018 Poster Presentations |
Search more.